Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility. - Wikidata - awgldk - TriplyDB

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

http://www.wikidata.org/entity/Q36638117

about

Angiopoietin-Like Proteins: A Comprehensive Look Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138.miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein.Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors Retinoic acid receptor beta and angiopoietin-like protein 1 are involved in the regulation of human androgen biosynthesis.A high-throughput mechanofluidic screening platform for investigating tumor cell adhesion during metastasis.ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.MiR-630 Inhibits Endothelial-Mesenchymal Transition by Targeting Slug in Traumatic Heterotopic Ossification.MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.MiR-630 suppresses breast cancer progression by targeting metadherin.Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.Angiopoietin-like proteins 3, 4 and 8: regulating lipid metabolism and providing new hope for metabolic syndrome.Screening of the prognostic targets for breast cancer based co-expression modules analysis.MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.miR-630 functions as a tumor oncogene in renal cell carcinoma Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells.miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer.A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab.Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells.Epigenetic impacts of ascorbate on human metastatic melanoma cells.Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.Circulating Plasma Extracellular Microvesicle MicroRNA Cargo and Endothelial Dysfunction in Children with Obstructive Sleep Apnea Thy-1 dependent uptake of mesenchymal stem cell-derived extracellular vesicles blocks myofibroblastic differentiation.Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma.A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.

P2860

Q29395294-3193FCEB-A4B4-4DE9-BA86-0C05B829F9BB Q33634316-A00C6E97-B1B6-4932-BE3D-D1D2E5D41D21 Q33786626-CE7864E6-7F35-4C2A-99CA-AF3DB09E6A7B Q34524533-2D745A1D-2F2D-49EC-B3AC-89B000E5984C Q35167131-C992043E-37B3-41B1-96D6-EFB75FFF7D77 Q35176196-CE22A1ED-C26B-42A8-85C4-88CD6180475A Q35599870-15995E20-7705-4B17-B33E-0C129CF6C656 Q35846178-AEB51DC1-5622-4280-AAC3-DE798D75F284 Q36356225-405800B4-2031-4CF6-8622-14F90538A735 Q36651240-CB1FDCF7-CA38-4A68-A43C-E1715181EA50 Q36655845-4B0FCFE0-6F51-44E8-8453-1FE9BE81376D Q36738807-2367FC6C-D15E-445C-8B9B-454DA13C0878 Q37062821-8DC22899-3B77-4656-89E9-42782B1C9564 Q37225640-0DC6EEDB-F30E-4A78-992D-1C2E490F0FBD Q37505854-6957C970-C323-4401-919D-7EEF6C54C017 Q37536575-FB3CADCA-6FC7-425F-87B7-D8481686B5D4 Q38222802-2191BAD8-2BF2-48D0-B583-56CFA676DE56 Q38430904-48AFC511-F925-4668-A5A0-8DE516C4DEB0 Q38749995-A9627986-3A05-43FB-8A7D-B6927C45899A Q38765549-14189381-17D5-4768-8B1C-3CDDCBC79BB5 Q38942696-F40557A1-E656-48F7-ADBA-26D342B55CE5 Q38968611-ACF75F8B-8E6A-441F-994B-3E4A0A2329CF Q39616746-7E814DEC-9E74-48F0-88BF-C2741ED608DE Q41099919-4326DCE4-2EA0-40EC-971D-8371984E2B0A Q42002131-B557FE19-5C44-4F02-9745-BBD7658224B6 Q42704760-CBE08A97-F357-4AC1-9501-DD6D47DFFCBA Q42752965-04416031-700C-4952-9CA2-2C3A8EAFFA50 Q47108155-A1285C3F-8064-45CA-A1E1-FD62561CD46C Q47699400-FB1DE365-99E9-4066-8C3A-D7C647D8DF57 Q51568263-3376A7FE-C0F0-4463-858A-AAAA3898AFEA Q54939484-AE9E656C-2ACD-495E-86A4-BB6A7AB827A7

P2860

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

http://www.wikidata.org/entity/Q36638117

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

@ast

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

@en

type

label

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

@ast

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

@en

prefLabel

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

@ast

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

@en

P1433

Q36638117-78AB9D1E-1F70-4D09-90EF-20866E8EE70D

P1476

Q36638117-ECC5902B-590E-4174-BD5F-49E7BA9AD312

P2093

Q36638117-01767CDF-5DF9-4880-85B7-C3D285D0C771

Q36638117-0F9E753B-D6EC-4BF8-8F7B-11B23C19B12B

Q36638117-28C87BFE-1471-4DAA-BB6F-8C885AA1A60D

Q36638117-3C908F33-5F6D-41B0-834E-CC885244D963

Q36638117-4A7807E8-EAAB-4D8B-B928-8532E30CD86B

Q36638117-5176C29B-FD62-4DEC-B02D-40E14306B8EF

Q36638117-62AEFE21-6712-4C78-BF23-667FC928A1A3

Q36638117-85B97EC7-8F2C-489C-868B-70FADF3E71E6

Q36638117-875B9B35-7109-48CF-9BF3-1C6727831B4E

Q36638117-B506999A-BEA5-4712-B8CF-125F89912F72

P2860

Q36638117-09B15288-85F7-4196-A519-6A5E80684F4D

Q36638117-0FC14072-78E9-4B6B-A892-954200281BDF

Q36638117-14C0AC20-013D-484F-AE6B-579B199D7FB8

Q36638117-15B1BCA0-DF23-4603-BDBA-6E2D74C19C68

Q36638117-16C7D0F0-3D3C-4E91-B706-15B8B8D728C0

Q36638117-16E97079-3A56-4A79-8F4D-5D9A03E6CEFD

Q36638117-22922F84-B625-43AE-8AA7-480A3EFC6370

Q36638117-2C07C82A-03B5-49F9-873D-89F99A2F353B

Q36638117-2D11560C-7389-4CBB-B7AF-465BB48D11CE

Q36638117-2D4A5447-DACD-42F6-90BA-902792469525

P304

Q36638117-612F69D5-A59B-4CA2-9132-F3D0B277043A

P31

Q36638117-DE972B78-2F48-4FB9-9888-2C37FC285A17

P356

Q36638117-D47C40F4-A909-4B0C-BB9B-D48E791F1C18

P407

Q36638117-87E23ACE-6714-4EF5-82B5-EADA659E1BFC

P433

Q36638117-CC14976C-2134-433F-B86D-C6CD261A9C02

P478

Q36638117-9A0E3DD9-2309-4408-A04E-122527C4E6C3

P50

Q36638117-35A35BA8-23A8-4FC1-A5CC-15AA5D2EF617

Q36638117-B021BAA2-422D-428B-8740-07897C1EB4EE

Q36638117-DCD23AED-10DA-4E61-A2E4-8585ED6C8E91

Q36638117-E448CAEB-31DE-42DD-8CE4-27E64B0A44FF

P577

Q36638117-677EC12D-A9FE-49AC-9B3C-962AE31EA152

P5875

Q36638117-56EF37E9-2C1A-483E-9766-B6C3E27C8F9D

P698

Q36638117-A00C4BF2-A399-47E7-9D3D-16888F85CCEC

P932

Q36638117-54AFFAB4-B1EE-449C-9BB7-0D7CBF4F30CC

P356

P1433

Journal of Clinical Investigation

P1476

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

@en

P2093

Chih-Chen Hong

http://www.w3.org/2001/XMLSchema#string

Jean Chiou

http://www.w3.org/2001/XMLSchema#string

Jen-Liang Su

http://www.w3.org/2001/XMLSchema#string

Min-Wei Chen

http://www.w3.org/2001/XMLSchema#string

Ming-Yang Wang

http://www.w3.org/2001/XMLSchema#string

Pai-Sheng Chen

http://www.w3.org/2001/XMLSchema#string

Pei Yu

http://www.w3.org/2001/XMLSchema#string

Tsang-Chih Kuo

http://www.w3.org/2001/XMLSchema#string

Wei-Jiunn Lee

http://www.w3.org/2001/XMLSchema#string

Yi-Wen Chang

http://www.w3.org/2001/XMLSchema#string

P2860

ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo

Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

The functions of animal microRNAs

Oncomirs - microRNAs with a role in cancer

MicroRNAs: genomics, biogenesis, mechanism, and function

P304

1082-1095

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI64044

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235716045

http://www.w3.org/2001/XMLSchema#string

P698

23434592

http://www.w3.org/2001/XMLSchema#string

P932

3582121

http://www.w3.org/2001/XMLSchema#string